Mevox

Private

LondonHealthcare & Life Scienceshttps://mevoxltd.com/

Last Round

Series A

Feb 11, 2021

Total Funding Raised

$6.08M

Company Overview

Mevox is a pharmaceuticals and biotechnology company that develops optimized protein vaccines designed to induce higher antibody levels.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

protein vaccinesvaccine developmentstructure-based designantigen designrational vaccine designmolecular characterizationcomputational vaccine designvaccine R&DAI-augmented drug discoveryin silico designstructural biologybiopharmaceutical partnershipsbioinformaticsvaccine technology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mevox Comparables

Compare Mevox with similar companies based on industry and business-model similarity.

Mevox comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Baseimmune	79%
Lovaltech	77%
SpyBiotech	75%

View all Comparables

Mevox Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Feb 11, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Conor Woolfson

Chief Financial Officer

Executive Team

Mevox Investors

Notable investors and investment history

Mevox investors
Investor	Rounds
Morningside Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 11, 2021
$6M round led by Morningside Ventures.

View all signals

Mevox Filings

Explore SEC and related filing metadata, where available.

Mevox filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersLondon

Employee Range2

Year Founded2019

Last FundingFeb 11, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?